Growth through launches Opportunity to engage with OptiBiotix around new product launches such as FeelFull and SlimBiome containing products, particularly leveraging US and India market rollouts to upsell formulation services, regulatory support, and co-branding opportunities.

Global expansion Target potential partnerships and distribution deals in international markets where OptiBiotix is expanding (US, India) including manufacturing partnerships and private label opportunities with local distributors, leveraging their Indian subsidiary’s manufacturing agreement with KAG Industries.

Platform leverage Position as a supplier of platform-enabled microbiome formulations and tracking data capabilities (OptiScreen and OptiBiotic) to complement customer product development, R&D collaborations, and regulatory submissions across nutraceuticals and metabolic health sectors.

Financial stability With modest revenue and a current funding runway, offer scalable pilot contracts and bundled services to prove value quickly, aiming to convert pilots into longer-term collaborations and co-development funding rounds.

Leadership & IP Engage executive-level discussions with new Finance Director to align on budget-friendly commercialization strategies, while emphasizing proprietary microbiome platforms and intellectual property to differentiate offerings to potential partners and customers.